TELEO Capital Acquires Applied Materials’ Pharmaceutical Manufacturing Intelligence Platform

TELEO Capital Management, LLC has acquired SmartFactory Rx (“SmartFactory” or “Modersys”), a leading pharmaceutical manufacturing intelligence platform, from Applied Materials, Inc. SmartFactory has been rebranded as Modersys as part of the transaction.

Modersys is designed to help biopharmaceutical, nutritional, and other life sciences companies improve yield, reduce variability, accelerate time to market, and maintain regulatory fidelity. Its platform combines real-time analytics, AI/ML process intelligence, advanced process control, adaptive scheduling, and alarm management across the full manufacturing lifecycle – from early-stage process development through GMP commercial production. Modersys operational platform has been deployed across the U.S., Europe, and Asia Pacific for the world’s most demanding manufacturing environments.

Across customer deployments, the platform has delivered measurable results, including yield improvements of up to 10%, throughput gains of up to 15%, reductions in experimental effort of up to 50%, and equipment availability gains of more than 22 days per plant per year, according to the company.

“Modersys represents exactly the kind of mission-critical, deeply differentiated software platform that we were built to acquire,” said TELEO Capital. As an independent company, Modersys will have the focus, investment, and agility to accelerate product innovation to meet customer demands globally.”